Y-Intercept »

Kalvista Pharmaceuticals shares owned by Y-Intercept

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-03-31 $680k 34k 20.13

More positions owned by Y-Intercept

Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Doordash Cl A (DASH)
Eli Lilly & Co. (LLY)
Sandisk Corp (SNDK)
Capital One Financial (COF)
Emerson Electric (EMR)
Boston Scientific Corporation (BSX)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Roblox Corp Cl A (RBLX)
Lam Research Corp Com New (LRCX)
Servicenow (NOW)
Sea Sponsord Ads (SE)

View all positions for Y-Intercept

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals